Revised SPCs: Kisplyx (lenvatinib) hard capsules

The SPC has been updated to note that in patients with renal cell carcinoma, the pharmacokinetics of everolimus were not significantly affected by concomitant lenvatinib. This is based on data from study 221, a single-arm, multicentre, Phase 2 trial.

Source:

electronic Medicines compendium